2,2-dimethyl-3-((R)-2-oxo-6-phenyl-3-((S)-1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethyl)-1,3-oxazinan-6-yl)propanenitrile → 5-(4-((S)-1-((R)-6-(2-cyano-2-methylpropyl)-2-oxo-6-phenyl-1,3-oxazinan-3-yl)ethyl)phenyl)-N-cyclopropylpyrimidine-2-carboxamide

Participants

Reaction Steps

The title compound was prepared from 2,2-dimethyl-3-((R)-2-oxo-6-phenyl-3-((S)-1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethyl)-1,3-oxazinan-6-yl)propanenitrile and 5-bromo-N-cyclopropylpyrimidine-2-carboxamide following a procedure analogous to that described in Example 1 Step 2. LC-MS Method 2 tR=1.237 min, m/z=524.3; 1H NMR (CDCl3) 0.62 (m, 2H), 0.83 (m, 2H), 1.32 (s, 3H), 1.44 (s, 3H), 1.49 (d, 3H), 2.08 (m, 2H), 2.24 (m, 1H), 2.42 (m, 2H), 2.90 (m, 2H), 5.61 (m, 1H), 6.93 (m, 2H), 7.20-7.36 (m, 7H), 8.00 (s, 1H), 8.88 (s, 2H).

Provenance & Evidence